Akeso
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
21 Bloomsbury Way, London, Greater Londo...Phone Number
+44 2030111381Website
www.akesoco.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Akeso
Akeso is an independent management consultancy specializing in healthcare and life sciences, offering expertise in areas such as Procurement, Supply Chain, and Healthcare Operations. They provide a range of services including Strategy & Operating Model, Financial & Performance Improvement, Change & Transformation, and Data & Analytics. Their intended clients include organizations within the health and care sectors, as well as MedTech and life sciences companies. Akeso is committed to delivering meaningful and sustainable improvements through their consulting and analytic offerings.Explore more
Akeso Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Akeso your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Akeso is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Akeso launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Akeso has new funding data
Congratulate Masked Content for being promoted to Masked Content at Akeso
Click to see if Akeso had a recent Job posting/layoffs
Earning: See what the market has to say on Akeso recently announced quarterly report
Check if Akeso has recently received funding, and reach out quickly before it becomes old news!
Akeso, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Akeso
Compare insights from companies similar to Akeso, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Akeso is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Akeso is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Akeso.
Akeso Tech Stack
A closer look at the technologies used by Akeso
Akeso News & Media
Akeso releases promising data of Ivonescimab (PD-1/VEGF BsAbs, AK112) for advanced NSCLC at ASCO 2022
HONG KONG, June 5, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, released clinical details in poster presentation featuring...Akeso releases promising data of Ivonescimab (PD-1/VEGF BsAbs, AK112) combined with chemotherapy in advanced NSCLC at ASCO 2022
HONG KONG, June 5, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, released clinical details in poster discussion featuring a...Akeso announces oral presentation featuring promising clinical data of Cadonilimab (PD-1/CTLA-4 BsAbs, AK104) for the first-line treatment of R/M cervical cancer at ASCO 2022
HONG KONG, June 5, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, released updated results of Cadonilimab (PD-1/CTLA-4...Akeso Publishes Preclinical Results of PD-1/LAG-3 Bi-specific Antibody（AK129）at the American Association for Cancer Research (AACR) 2022 Annual Meeting
HONG KONG, April 14, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, announced the publication of preclinical results of its...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Akeso
Sign Up For FreeTo access detailed company insights
Akeso is an independent management consultancy specializing in healthcare and life sciences, offering expertise in areas such as Procurement, Supply Chain, and Healthcare Operations. They provide a range of services including Strategy & Operating Model, Financial & Performance Improvement, Change & Transformation, and Data & Analytics. Their intend... Read More
